
Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure
Author(s) -
Emran Kuzey Avcı,
Gülçin Alp Avcı,
Berrın Özçelık,
Şule Çoşkun Cevher,
Menderes Suíçmez
Publication year - 2017
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2017_035
Subject(s) - hemodialysis , medicine , pathogenesis , nephropathy , biomarker , chronic renal failure , diabetic nephropathy , renal function , transforming growth factor , kidney disease , cytokine , gastroenterology , endocrinology , urology , kidney , diabetes mellitus , biology , biochemistry
Our study focuses on the determination and evaluation of TGF-β1 levels of patients receiving hemodialysis treatment because of chronic renal failure.